We work with policy-makers, clinicians, academia and industry to develop future-focused healthcare strategies for safe and suitable use of innovations, such as diagnostics, genome editing and regenerative medicines. Only through understanding the benefits – and complexities – of genomics-based innovations and other ‘omics sciences can we help everyone benefit from great science.
